Add Yahoo as a preferred source to see more of our stories on Google. Johnson & Johnson's Abiomed alerted physicians to a risk associated with eight instances of major bleeding in patients treated ...

A new warning is being issued over a heart pump whose use could perforate the heart. The device has already been linked to over 100 injuries and 49 deaths. These left-sided Impella heart pumps are ...

For circulatory support in cardiogenic shock, the best choice between Impella and intra-aortic balloon pump (IABP) has been controversial. Now, new data is complicating the debate. Presenting at the ...

Patients relying on a temporary heart pump to stay alive face a direct threat: the FDA classified a recall of Abiomed’s ...

A troubled heart pump that has now been linked to 49 deaths and dozens of injuries worldwide will be allowed to remain in use, despite the Food and Drug Administration’s decision to issue an alert ...

A third-party randomized trial from King’s College London is being cited as the reason Johnson & Johnson’s Impella usage has ...

An international trial of the Impella heart pump in patients with ST elevation myocardial infarction (STEMI) and cardiogenic shock has been stopped by the sponsor Abiomed, Inc. The termination ...

Add Yahoo as a preferred source to see more of our stories on Google. Johnson & Johnson's Impella CP heart pump in an illustration of the heart. Johnson & Johnson’s Impella heart pump failed to lower ...

Results from the first randomized trial of Impella pumps during complex stent procedures, published in the New England Journal of Medicine, have shown that the pumps offer no significant benefit to ...

Impella heart pumps were first cleared for use in 2008, and their use was contested among cardiologists even before the recent spate of problematic reports. When the one model of the device was ...